Improving recovery after child stem cell transplant
Treatments studied
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests different ways to help children recover after a stem cell transplant (a procedure that replaces damaged blood cells). It aims to reduce complications and improve overall health outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged from over 1 week to 18 years old
- Planning to have a stem cell transplant from a donor within the next 4 months
- A suitable donor must be identified
- Not in a situation where death is imminent and full treatment is not being pursued
- May be asked to join optional sub-studies with additional criteria
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different ways to manage stem cell transplants in children and young adults with acute lymphoblastic leukemia (ALL). It aims to find the best approach to improve outcomes and reduce complications.
This trial tests whether adding back certain immune cells after a stem cell transplant can help prevent serious viral or fungal infections. It's for children and young adults up to age 25 who need a transplant for a blood cancer or other curable disease.
This trial tests whether an adapted physical activity (tailored exercise) can help people recover after a donor stem cell transplant for blood cancers. If you’re able to participate, the program may support strength, well-being, and recovery during the transplant process.
This study tests whether exercise and health counseling can help children and young people recovering from a stem cell transplant for cancer. Participants will be assigned to either the exercise program or standard care, and the study will see how it affects their recovery and quality of life.
This trial gives patients access to a special machine that cleans stem cells before they are transplanted, which may reduce the risk of graft-versus-host disease. It is for patients getting certain types of stem cell transplants or having poor graft function after a transplant.
This trial studies a special donor stem cell transplant where the donor’s immune cells are reduced, aiming to lower harmful immune attacks after transplant. It may help children and young adults with certain high-risk blood cancers or rare bone marrow disorders.
Hear when a new Haematopoietic Stem Cell Transplant, Allogeneic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.